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The chicken anemia virus protein Apoptin selectively induces apoptosis in transformed cells while leaving
normal cells intact. This selectivity is thought to be largely due to cell type-specific localization: Apoptin is
cytoplasmic in primary cells and nuclear in transformed cells. The basis of Apoptin cell type-specific local-
ization and activity remains to be determined. Here we show that Apoptin is a nucleocytoplasmic shuttling
protein whose localization is mediated by an N-terminal nuclear export signal (NES) and a C-terminal nuclear
localization signal (NLS). Both signals are required for cell type-specific localization, since Apoptin fragments
containing either the NES or the NLS fail to differentially localize in transformed and primary cells. Signif-
icantly, cell type-specific localization can be conferred in trans by coexpression of the two separate fragments,
which interact through an Apoptin multimerization domain. We have previously shown that Apoptin interacts
with the APC1 subunit of the anaphase-promoting complex/cyclosome (APC/C), resulting in G2/M cell cycle
arrest and apoptosis in transformed cells. We found that the nucleocytoplasmic shuttling activity is critical for
efficient APC1 association and induction of apoptosis in transformed cells. Interestingly, both Apoptin mul-
timerization and APC1 interaction are mediated by domains that overlap with the NES and NLS sequences,
respectively. Apoptin expression in transformed cells induces the formation of PML nuclear bodies and
recruits APC/C to these subnuclear structures. Our results reveal a mechanism for the selective killing of
transformed cells by Apoptin.
Viruses employ diverse strategies to alter host cell functions
that, in turn, facilitate the viral life cycle. In this regard, many
viral proteins modulate critical cellular processes including
transcription, cell signaling, and cell cycle regulation. For ex-
ample, numerous DNA viruses encode proteins that target key
cell cycle regulators in mammalian cells such as p53 and pRB
(22, 55). Thus, the study of virus-host interactions has been
valuable in understanding a wide variety of cellular regulatory
pathways.
Many animal viruses encode proteins that are potent induc-
ers of apoptosis, a common mechanism to facilitate viral egress
and promote viral spreading (38). In certain cases the apop-
totic activity of the virus is selective to transformed cells. One
example is the Apoptin protein encoded by the chicken anemia
virus (CAV). CAV is the sole member of the family Circo-
viridae, genus Gyroviridae, and is the etiologic agent of chicken
infectious anemia, which results from large-scale apoptosis of
cortical thymocytes and erythroblastoid cells in the bone mar-
row (18). The CAV genome encodes three proteins; the third
protein, VP3 or Apoptin, is responsible for apoptosis induction
(32). We have previously shown that Apoptin interacts with the
anaphase-promoting complex/cyclosome (APC/C) (42), a major
regulator of cell cycle function (reviewed in reference 33). The
entry of Apoptin into the nucleus is followed by the inhibition of
the APC/C, which leads to cell cycle arrest in G2/M and subse-
quent induction of apoptosis (42).
Two properties of CAV Apoptin make it of particular inter-
est to study cancer-specific processes. First, as stated above,
Apoptin selectively induces apoptosis in transformed cells
while leaving primary normal cells intact (7). Transient or
long-term expression of Apoptin in primary cells has no dele-
terious effects. Second, induction of apoptosis in transformed
cells occurs irrespective of the status of the p53 tumor suppres-
sor gene (8). The p53 pathway is the major mechanism by
which cancer cells are destroyed by chemotherapy and radio-
therapy (41). However, because the p53 gene is mutated in
approximately half of all human tumors, cancer cells are often
refractory to these forms of therapy (40). Therefore, the study
of Apoptin represents a system for studying novel p53-inde-
pendent pathways to apoptosis in cancer cells.
The transformed cell-specific killing effects of Apoptin are
largely related to differences in subcellular localization of the
protein. In primary cells, Apoptin is localized in the cytoplasm,
whereas in transformed cells, Apoptin is nuclear (7). The basis
for this cell type-specific localization remains to be deter-
mined. We have previously demonstrated that in primary cells
Apoptin exists in a more aggregated form in the cytoplasm and
may be associated with filament networks (42). This differen-
tial localization of Apoptin is highly unique and the study of
cellular mechanisms regulating this behavior may provide valu-
able insights into transformed cell physiology. In the present
study we address the basis of Apoptin cell type-specific local-
ization and activity. Our results, in conjunction with previous
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studies, enable us to propose a model for Apoptin-induced
transformed cell-selective killing.
MATERIALS AND METHODS
Cells and adenoviruses. Primary foreskin fibroblast (PFF), H1299, and
HA1-IM (S. Bacchetti, McMaster University, Hamilton, Ontario, Canada) cells
were maintained in Dulbecco modified Eagle medium (DMEM) supplemented
with 10% fetal bovine serum plus 10 g of streptomycin/ml and 10 U of peni-
cillin/ml (Sigma, St. Louis, MO) at 37°C under 5% CO2 (95% air). Apoptin
adenoviruses (42) and the LacZ adenovirus (Ad-LacZ) (3) were prepared as
previously described. Cells were infected at 80% confluence at a multiplicity of
infection of 35. Adenovirus was added to cells in a minimal volume of culture
media and gently agitated at 37°C under 5% CO2 for 1 h. After infection, culture
medium was added, and cells were incubated for the indicated times.
Plasmid constructions. The green fluorescent protein-Apoptin construct
(GFP-Apwt) and deletion mutants have been described previously (42). GFP-
Ap-pmNES, -pmNLS, and -pmNLS2 were generated by PCR site-directed mu-
tagenesis. DsRed-Apoptin fusions were generated by PCR amplification of GFP-
Apoptin templates, followed by cloning into pDsRed1-N1 (Clontech, Palo Alto,
CA). For the dsRed-Ap(82-121) construct, a start codon was added because the
endogenous Apoptin 5 sequence had been removed. GFP-Ap-RevNES was
generated by replacing the wild-type Apoptin nuclear export signal (NES) se-
quence with an oligonucleotide linker containing the human immunodeficiency
virus type 1 (HIV-1) Rev NES. GFP-Ap-SV40NLS was made by PCR amplifi-
cation of Apoptin amino acids 1 to 88 with simultaneous addition of simian virus
40 (SV40) large T nuclear localization signal (NLS) sequence (PKKKRKV) to
the C terminus, followed by cloning into pEGFP-C1. To generate the dsRed-
dnRan fusion, a construct expressing dnRan (Lan Xu, University of Massachu-
setts Medical School, Worcester, MA) was PCR amplified and cloned in frame
into pDsRed1-N1. All constructs were confirmed by restriction digest analysis
and DNA sequencing.
Immunofluorescence and fluorescence microscopy. Ad-Apwt-infected PFF
and HA1-IM cells were fixed in 4% paraformaldehyde (in phosphate-buffered
saline [PBS]), permeabilized in 0.5% Triton X-100 (in PBS), and stained with
-Flag M5 primary monoclonal antibody (MAb; Sigma), followed by -mouse
immunoglobulin G Texas Red-conjugated secondary antibody (Sigma). H1299
cells were transiently transfected by using Effectene reagent and after 16 h, fixed
in 4% paraformaldehyde, and stained with either -Cdc27 MAb (Santa Cruz) or
-PML MAb (Santa Cruz), followed by Cy3-conjugated -mouse secondary
antibody. Cells were mounted on slides and observed by using a Zeiss Axiophot2
fluorescence microscope using Axiovision 4.4 software. Images shown are rep-
resentative examples.
For fluorescence microscopy, H1299 cells were transiently transfected by using
Effectene reagent (QIAGEN, Valencia, CA), and PFF transfections were per-
formed using an Amaxa Nucleofector. After 24 h, cells were fixed in 4% para-
formaldehyde and stained with DAPI (4,6-diamidino-2-phenylindole). Cells
were mounted and visualized as described above.
Quantification of the nuclear/cytoplasmic ratio was performed by densitomet-
ric analysis of nuclear and cytoplasmic fluorescence signals for at least three
regions of interest (ROI) using Axiovision 4.4 software. Background levels of
fluorescence were subtracted from average ROI values, and the ratios of nuclear
to cytoplasmic signal were calculated and are represented as histograms.
Nucleocytoplasmic shuttling assays. A total of 5  105 PFF cells were
transiently transfected with GFP-Apwt and 24 h later were treated with lepto-
mycin B (LMB) at a final concentration of 2.5 ng/ml. A total of 5  105 H1299
cells were transfected with GFP-Apwt or Rev-GFP and 12 h later were trans-
fected with a construct expressing dsRed-dnRan. Cells were visualized by fluo-
rescence microscopy 8 to 12 h later to minimize effects due to protein synthesis
or turnover.
Heterokaryon assays. A total of 5  105 H1299 or PFF cells were transiently
transfected with dsRed-Apwt or GFP-Apwt, respectively, by Amaxa nucleofec-
tion. Immediately after transfection, cells were either mixed or plated separately
(for controls) in six-well format on coverslips and left to recover for 12 h. The
medium was then removed, and the cells were washed twice in PBS and fused by
exposure to a solution of 50% polyethylene glycol 1000 (PEG 1000) in serum-
free DMEM for 125 s at room temperature. PEG solution was then removed by
a wash with PBS, and fresh medium was added. After overnight recovery, cells
were fixed in 4% paraformaldehyde (in PBS) and stained with DAPI, and
Apoptin localization was determined by fluorescence microscopy.
Immunoprecipitations and immunoblotting. For multimerization experi-
ments, 107 H1299 cells were transiently transfected with GFP-Apoptin trun-
cation mutants by using Effectene. After 12 h cells were infected with Ad-Apwt
and incubated for 24 h. Cells were harvested and lysed in buffer X (50 mM Tris
[pH 8.5], 250 mM NaCl, 1 mM EDTA, 1% NP-40, Complete Mini tablet [Roche,
Basel, Switzerland]) on ice for 20 min. Cell debris was removed by centrifugation,
and supernatants were incubated with 30 l of Ezview Red -Flag M2 affinity
beads (Sigma) at 4°C for 4 h. Beads were then washed in buffer X, and bound
proteins were eluted by boiling in sodium dodecyl sulfate (SDS) sample buffer.
For solubility analysis, 107 H1299 or PFF cells were infected with Ad-Apwt,
followed by incubation for 48 h. Cells were then harvested and immunopre-
cipitated as described above. For APC1 association studies, 107 H1299 cells
were transiently transfected with Flag-Apoptin constructs, followed by 48 h of
incubation. Cells were then harvested and immunoprecipitated as indicated
above. For all experiments, whole-cell extracts were prepared by washing cells
once in 1 PBS, resuspension in 1 SDS sample buffer, and incubation at
95°C for 5 min.
For immunoblotting, samples were resolved by SDS–polyacrylamide gel elec-
trophoresis with a 6 or 15% polyacrylamide gel and transferred to nitrocellulose.
Blots were blocked with 5% milk in TBS-T and probed with either -Flag M2
MAb (Sigma), -GFP MAb (Clontech), or -APC1 affinity-purified polyclonal
rabbit serum, followed by appropriate horseradish peroxidase-conjugated -im-
munoglobulin G secondary antibody (Amersham Biosciences). Protein bands
were visualized by chemiluminescence using SuperSignal substrate (Pierce,
Rockford, IL).
Cell viability and apoptosis assays. For cell viability assays, H1299 and PFF
cells infected with Ad-Apwt, Ad-pmNES, or Ad-LacZ were harvested, washed in
PBS, and stained with ViaCount reagent (Guava Technologies, Inc., Burlingame,
CA), and viability was quantitated by using a Guava Personal flow cytometer.
The datum points were collected as percent cell viability per 5,000 events.
Apoptosis assays were performed with GFP-Apoptin fusion proteins as previ-
ously described (42).
RESULTS
Apoptin is a nucleocytoplasmic shuttling protein. The abil-
ity of the CAV protein Apoptin to localize to either the nu-
cleus or the cytoplasm depending on cell type suggested that
the protein may undergo nucleocytoplasmic shuttling. To de-
termine whether Apoptin shuttles in primary cells, we tran-
siently transfected PFFs with a plasmid expressing Apoptin
fused to the C terminus of GFP (GFP-Apwt) and treated the
cells with LMB, a compound that specifically blocks Crm1-
mediated nuclear export (25, 52). If Apoptin shuttles in pri-
mary cells, then blocking nuclear export should result in the
accumulation of Apoptin in the nucleus. Figure 1A shows that
LMB treatment resulted in nuclear accumulation of GFP-
Apwt in PFFs. To verify this result, PFFs were infected with an
adenovirus expressing Flag-tagged Apoptin (42) and treated in
the presence or absence of LMB. Figure 1B shows, as ex-
pected, that LMB treatment resulted in nuclear accumulation
of Flag-Apwt. Consistent with our previous studies (42), Flag-
tagged Apoptin exhibited a filamentous staining pattern, which
was stable after LMB treatment.
To test whether Apoptin also shuttles in transformed cells,
we developed an assay to monitor the nucleocytoplasmic shut-
tling of a predominantly nuclear protein. In non-small-cell-
lung-carcinoma H1299 cells, we expressed a dominant-nega-
tive Ran GTPase mutant (dnRan), which blocks Ran-
dependent nuclear import (21). To validate this approach, we
performed a control experiment monitoring the effect of dn-
Ran on localization of HIV Rev, a well-characterized nucleo-
cytoplasmic shuttling protein (20, 30). Figure 1C shows, as
expected, that a dsRed-dnRan fusion-protein localized to the
nuclear periphery (13) and that a Rev-GFP fusion-protein
accumulated in the nucleolus (45). Coexpression of dsRed-
dnRan and Rev-GFP resulted in the loss of nuclear GFP sig-
nal, confirming that Rev-GFP exited the nucleus and was
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blocked for subsequent reentry. Similarly, expression of
dsRed-dnRan resulted in the loss of nuclear GFP-Apwt, indi-
cating that Apoptin shuttled in transformed cells. Collectively,
the data of Fig. 1A to C indicate that Apoptin localization is
regulated by nucleocytoplasmic shuttling in both primary and
transformed cells and that nuclear import and export are me-
diated by the common nuclear trafficking machinery.
Apoptin nuclear localization is mediated by a dominant
transformed cell-specific activity. To determine whether the
transformed or primary cell contained a dominant Apoptin
localization activity, we performed a heterokaryon experiment.
PFFs were transiently transfected with a plasmid expressing
GFP-Apwt, and H1299 cells were transiently transfected with a
plasmid expressing Apoptin fused to the C terminus of dsRed
(dsRed-Apwt). Twelve hours later, the cells were combined,
fused with polyethylene glycol, and allowed to recover over-
night. Figure 1D shows that when either PFF/GFP-Apwt or
H1299/dsRed-Apwt cells were self-fused, the expected local-
ization patterns were observed. However, fusion of PFF/GFP-
Apwt cells with H1299/dsRed-Apwt cells resulted in the trans-
location of PFF-derived GFP-Apwt to the nucleus where it
colocalized with dsRed-Apwt. These results indicate that trans-
formed cells contain a dominant activity that confers Apoptin
nuclear localization.
We also monitored localization of Apoptin in HA-1 cells, a
clonal population of human embryonic kidney cells trans-
formed with SV40 large T antigen that bypass senescence and
enter crisis (6). HA-1 cells were infected with Ad-Apwt and
Apoptin localization was monitored both before (passage 44)
and after (passage 94) crisis. Figure 1E shows that Apoptin
FIG. 1. Apoptin shuttles between the nucleus and cytoplasm in a Crm1-dependent manner. (A) PFF cells expressing GFP-Apwt were
treated in the presence or absence of LMB. (Top) 3 h later, Apoptin localization was visualized by fluorescence microscopy for GFP, and
nuclei were visualized by DAPI staining. (Bottom) The ratio of nuclear to cytoplasmic GFP-Apwt signal was quantified for the images
presented in the top panel. The dashed red line indicates a ratio of 1 (equal levels of nuclear and cytoplasmic fluorescence). Values greater
than 1 indicate predominantly nuclear localization, whereas values less than 1 indicate predominantly cytoplasmic localization. (B) PFF cells
were infected with an adenovirus expressing Flag-Apoptin (Ad-Apwt) and treated in the presence or absence of LMB. Cells were stained
with an -Flag antibody, and immunofluorescence analysis was performed 24 h postinfection. (C) H1299 cells were transfected with a
construct expressing dsRed-dnRan either alone (top panel) or 12 h after transfection with GFP-Apwt (bottom panel). As a control, H1299
cells were also transfected with either a GFP Rev-GFP fusion alone, Rev-GFP plus dsRed-dnRan, or GFP-Apwt (middle panels). At 12 h
after transfection, localization was monitored by fluorescence microscopy for dsRed (left) or GFP (middle) and by DAPI staining (merged,
right). Quantification of the nuclear/cytoplasmic GFP signal ratio for the images presented is shown. (D) Heterokaryon assay. (Top) PFFs
expressing GFP-Apwt and H1299 cells expressing dsRed-Apwt were either mixed or plated separately, incubated for 12 h, and subjected to
polyethylene glycol-induced fusion. (Bottom) Quantification of the nuclear/cytoplasmic GFP signal ratio for the images presented in the top
panel. (E) Immunofluorescence of HA-1 cells infected with Ad-Apwt precrisis (passage 44; upper panels) and postcrisis (passage 94; lower
panels). Cells were stained with an -Flag antibody (left) or DAPI (merged, right). (F) The solubility of Apoptin in PFF and H1299 cell
extracts was monitored by immunoprecipitation with an -Flag affinity resin, and the presence of Apoptin in the immunoprecipitate (top)
and WCE (bottom) was monitored by immunoblot analysis. Samples were normalized by equivalent cell number. (G) The solubility of
Apoptin in pre- and postcrisis HA-1 cells was monitored by immunoprecipitation as described in panel F.
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exhibited a filamentous, cytoskeleton-like cytoplasmic staining
pattern in precrisis cells, whereas in postcrisis cells Apoptin
localized predominantly to the nucleus. Thus, the dominant
activity in transformed cells that directs Apoptin to the nucleus
appears early during the transformation process.
Biochemical properties of Apoptin differ between primary
and transformed cells. We and others have previously re-
ported that Apoptin forms large cytoplasmic aggregates in
primary cells (7, 42). We hypothesized that this aggregation
may reflect a fundamental difference in the biochemical state
of Apoptin in primary versus transformed cells. The immuno-
precipitation experiment of Fig. 1F shows that Apoptin was
highly resistant to extraction with a low ionic strength buffer
from PFFs compared to H1299 cells. In fact, in primary cells
the majority of Apoptin was not solubilized even under high-
ionic-strength-conditions (data not shown). Figure 1G shows
that Apoptin derived from precrisis HA-1 cells was also highly
resistant to extraction compared to postcrisis cells in which
Apoptin was readily immunoprecipitated. These results sug-
gest that in transformed cells, nuclear translocation of Apoptin
coincides with a large increase in solubility of the protein. The
filamentous, cytoplasmic staining pattern observed in primary
cells (see Fig. 1B and E and references 7 and 42) suggests that
Apoptin may be tightly associated with cellular filament net-
works, which could explain the difference in solubility between
primary and transformed cells.
Functional characterization of Apoptin NES and NLS se-
quences. We next sought to characterize the specific sequence
elements that contribute to nucleocytoplasmic shuttling. Pre-
vious studies have noted a putative canonical NES comprising
amino acids 37 to 46 in the N terminus and a putative NLS
comprising residues 70 to 121 in the C terminus (shown in
Fig. 2A) (9, 47). To determine whether residues 37 to 46 are in
fact a functional NES, we constructed a mutant in which the
core residues leucine-44 and leucine-46 were mutated to ala-
nine (GFP-Ap-pmNES). Figure 2A shows that in PFFs GFP-
Ap-pmNES mislocalized to the nucleus, indicating that the
putative NES is functional and that NES-dependent transport
of Apoptin is required for cytoplasmic accumulation in primary
cells. The putative bipartite NLS contains two domains highly
enriched in lysine and arginine (residues 86 to 88 and residues
116 to 118). We constructed an NLS mutant in which both trios
of basic amino acids were mutated to alanine (Ap-pmNLS).
This mutant mislocalized to the cytoplasm in H1299 cells,
indicating the NLS is required for nuclear localization. Thus,
Apoptin contains both a functional NES and NLS, a finding
consistent with the nucleocytoplasmic shuttling activity de-
scribed above.
A recent study has suggested that the Apoptin N-terminal
region lacks an NES and that nuclear export is mediated by a
noncanonical, Crm1-dependent NES located near the C ter-
minus of the protein (34). To confirm our conclusion that the
Apoptin N-terminal region harbors a functional NES, we
sought to determine whether the N terminus was sufficient to
mediate nuclear export in a Crm1-dependent manner. H1299
cells were transfected with two GFP-fused Apoptin fragments,
GFP-Ap(1-48) or GFP-Ap(1-88), both of which contain the
N-terminal NES but lack the C-terminal NLS (see Fig. 2A) and
putative C-terminal NES (34). Figure 2B shows that both de-
rivatives displayed a predominantly cytoplasmic localization
pattern in H1299 cells, indicating the N-terminal NES is suf-
ficient to confer nuclear export. Moreover, treatment with
LMB resulted in an increased GFP signal in the nucleus, in-
dicating nuclear export was Crm1 dependent. These results
confirm our conclusion that the Apoptin N-terminal region
contains a functional, Crm1-dependent NES.
Apoptin fragments containing either the NES or NLS fail to
undergo cell type-specific localization. The simplest explana-
tion for the differential localization of Apoptin in primary and
transformed cells is that one of the localization signals is sub-
ject to cell type-specific regulation. For example, the NLS
might be active in transformed cells and inactive in primary
cells. To test this model, we analyzed the localization of GFP-
fused Apoptin fragments containing either the NLS or NES in
primary and transformed cells. Figure 3 shows that GFP-
Ap(42-88), which lacks both the NLS and the NES, displayed
a diffuse homogeneous localization pattern in both H1299 and
PFF cells similar to that of GFP alone. As expected, the GFP-
Ap(1-48) and GFP-Ap(1-88) mutants, which contain the N-
terminal NES but lack the C-terminal NLS, displayed a pre-
dominantly cytoplasmic localization pattern in PFFs and, as
shown above, in H1299 cells, indicating the NES is active in
transformed cells. Conversely, the GFP-Ap(42-121) and GFP-
Ap(82-121) mutants, which contain the C-terminal NLS but
lack the N-terminal NES, localized to the nucleus in H1299
cells, as well as in PFFs, indicating the NLS is active in primary
cells. Thus, the NLS and NES are active in both primary and
transformed cells and, when uncoupled, both localization sig-
nals function constitutively.
trans restoration of Apoptin cell type-specific localization
through protein multimerization. Previous studies have shown
that purified, recombinant Apoptin aggregates in vitro (28),
raising the possibility that Apoptin functions as a multimer in
vivo. As a first test of this possibility, we sought to determine
whether cell type-specific localization could be restored in
trans by coexpression of two Apoptin fragments, one contain-
ing the NLS and the other containing the NES. Figure 4A
shows, as expected, that GFP-Ap-pmNLS, which lacks a func-
tional NLS, localized to the cytoplasm of both H1299 cells and
PFFs, whereas dsRed-Ap-pmNES, which lacks a functional
NES, localized to the nucleus in both H1299 cells and PFFs.
However, coexpression of GFP-Ap-pmNLS and dsRed-Ap-
pmNES resulted in the localization of both proteins to the
nucleus of H1299 cells and the cytoplasm of PFFs. These
results suggest that Apoptin is a multimer in vivo and confirm
that both localization signals are required for proper cell type-
specific localization.
To verify that Apoptin is a multimer in vivo and to map the
multimerization domain, we performed a series of coimmuno-
precipitation experiments. H1299 cells were transfected with a
series of GFP-fused Apoptin derivatives and 12 h later infected
with Flag-tagged Ad-Apwt. At 24 h after infection, Flag-Apop-
tin was immunoprecipitated, and the immunoprecipitate was
analyzed by immunoblotting with an -GFP antibody. Figure
4B shows that only derivatives containing the N-terminal third
of Apoptin [GFP-Apwt, GFP-Ap(1-48), GFP-Ap(1-88)] coim-
munoprecipitated with the Flag-Apoptin, indicating that this
region mediates protein multimerization.
To confirm the results of the coimmunoprecipitation exper-
iments and to verify that multimerization is the basis for res-
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toration of cell type-specific localization in trans, we analyzed
three additional Apoptin derivatives in the trans-expression
assay. Figure 4C shows that expression of dsRed-Apwt or
dsRed-Ap-pmNES restored nuclear localization to the consti-
tutively cytoplasmic GFP-Ap(1-88) mutant in transformed
cells and maintained cytoplasmic localization in primary cells.
In contrast, dsRed-Ap(82-121) failed to alter cytoplasmic lo-
calization of GFP-Ap(1-88) in transformed cells, indicating
that the N-terminal multimerization domain is required for
trans-association of the localization signals. These results show
that the activity of a constitutively cytoplasmic mutant can be
restored by expressing an NLS-containing C-terminal fragment
in trans.
The specific Apoptin NES is required for cell type-specific
localization. We next sought to determine whether the specific
sequence of the Apoptin NES and NLS were required for cell
type-specific localization by determining whether they could be
functionally substituted with heterologous localization signals.
Figure 5A shows that replacement of the Apoptin NLS with
that of SV40 large T antigen (Ap-SV40NLS) resulted in nu-
clear localization in H1299 cells and predominantly cytoplas-
mic localization in PFFs. Thus, the SV40 large T antigen NLS
can functionally substitute for the Apoptin NLS. In contrast,
replacement of the Apoptin NES with that of Rev (Ap-
RevNES), a well-established, prototypical NES (15, 31, 50),
resulted in a similar diffuse localization pattern in both H1299
and PFFs, indicating that the specific sequence of the Apoptin
NES is critical for proper cell type-specific localization.
Apoptin NES and multimerization domains overlap. One
explanation for the failure of the Rev NES to functionally
substitute for the Apoptin NES is that the Apoptin NES pro-
vides an activity in addition to nuclear export. Because both
FIG. 2. Apoptin contains a functional NES and NLS. (A) (Top) Schematic diagrams of N-terminal GFP-tagged Apoptin NES and NLS
mutants. (Middle) H1299 and PFF cells expressing GFP-Apoptin mutants were monitored by fluorescence microscopy for GFP (left) and DAPI
staining (merged, right). (Bottom) Quantification of the nuclear/cytoplasmic GFP signal ratio for the images presented in the middle panel.
(B) (Top) Schematic diagrams. (Middle) H1299 cells expressing GFP-Ap(1-48) or GFP-Ap(1-88) were treated in the presence of LMB. After 3 h,
Apoptin localization was visualized by fluorescence microscopy for GFP, and nuclei were visualized by DAPI staining. Nuclear entry is presumably
facilitated by passive diffusion of the small GFP-Apoptin truncated proteins. (Bottom) Quantification of the nuclear/cytoplasmic GFP signal ratio
for the images presented in the middle panel.
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the NES and the multimerization domain map to the N ter-
minus, we reasoned that the NES might be an essential part of
the multimerization domain. To test this possibility, we ana-
lyzed the two NES derivatives, Ap-pmNES and Ap-RevNES,
for their ability to multimerize in the coimmunoprecipitation
assay. Figure 5B shows that, compared to GFP-Apwt, the
GFP-Ap-pmNES mutant showed a somewhat reduced ability
to interact with Flag-Apoptin. Significantly, GFP-Ap-RevNES,
which contains a functional NES that differs at multiple resi-
dues from the Apoptin NES, failed to detectably coimmuno-
precipitate with Flag-Apoptin. Interestingly, the intermediate
level of multimerization observed with the Ap-pmNES mutant
was sufficient to confer function in the trans assay (see Fig. 4);
however, quantification of Fig. 4C revealed that Ap-pmNES
was less effective than wild-type Apoptin in mediating trans
localization (the nuclear/cytoplasmic ratios were 1.57 and 2.50,
respectively), which presumably reflected the decreased mul-
timerization efficiency. Together, these results suggest that the
Apoptin multimerization domain overlaps with the NES.
The NLS and nucleocytoplasmic shuttling are required for
APC1 interaction and Apoptin-induced cell death. The exper-
iments described above address the contribution of the NES
and NLS to protein localization but do not indicate whether
these sequences are required for the ability of Apoptin to
induce apoptosis. To investigate the role of the NLS, we con-
structed a second NLS mutant in which lysine-116, arginine-
117, and arginine-118 were mutated to alanine (Ap-pmNLS2;
Fig. 6A). This mutant protein retained partial nuclear local-
ization in H1299 cells (Fig. 6B). We also analyzed the Ap-
SV40NLS mutant, which localized exclusively in the nucleus in
H1299 cells (see Fig. 5A). To determine the ability of these two
mutants to induce cell death in transformed cells, GFP-Apwt,
GFP-Ap-pmNLS2, and GFP-Ap-SV40NLS were transiently
expressed in H1299 cells and, 3 days after transfection, the cells
were fixed, stained with DAPI, and analyzed by microscopy for
apoptotic morphology. As expected, cells expressing GFP-
Apwt underwent pronounced apoptosis, whereas the ability of
the Ap-pmNLS2 and Ap-SV40NLS mutants to induce apop-
tosis was severely reduced (Fig. 6C, top).
To understand why the Ap-pmNLS2 and Ap-SV40NLS mu-
tants failed to induce apoptosis in transformed cells even
though they localized to the nucleus, we next monitored their
ability to interact with the APC1 subunit of the APC/C, which
we have previously shown interacts with the C terminus of
Apoptin (42). A triple Flag-tagged version of each mutant was
transiently transfected into H1299 cells and immunoprecipi-
tated with an -Flag antibody, and the immunoprecipitate was
analyzed for APC1 by immunoblotting. As expected, APC1
was present in the immunoprecipitate from wild-type Apoptin
but not in that of the Ap-pmNLS2 or Ap-SV40NLS mutants
(Fig. 6C, bottom) despite the presence of both of these mu-
tants in the nucleus. These observations are consistent with our
previous results (42) and suggest that the NLS sequence over-
laps with the domain required for association with APC1. Fur-
thermore, these results indicate that nuclear localization in the
absence of APC1 association is not sufficient to induce apop-
tosis.
To assess the involvement of the NES in Apoptin-induced
cell death, we next investigated the ability of the Ap-pmNES
mutant, which contains a wild-type C-terminal domain and
localizes to the nucleus in transformed and primary cells (see
Fig. 2A), to interact with APC1 and induce apoptosis. Figure
6D shows that despite its nuclear localization, this mutant
failed to induce apoptosis in PFFs, a finding consistent with
previous studies showing that nuclear localization of Apoptin is
not sufficient to induce apoptosis in primary cells (9). Surpris-
ingly, however, this mutant also failed to induce apoptosis in
transformed cells (Fig. 6D, top) and exhibited greatly reduced
ability to interact with APC1 (Fig. 6D, bottom). The dnRan
assay of Fig. 6E shows, as expected, that the Ap-pmNES mu-
tant failed to undergo nucleocytoplasmic shuttling. Thus, the
shuttling activity of Apoptin is required for effective interac-
tion with APC1 and induction of apoptosis.
Apoptin recruits APC/C to PML bodies in transformed
cells. The fact that Apoptin interacts with APC1 (42) suggested
that in transformed cells Apoptin would colocalize with APC/C
complex. Because the APC1 antibody was not suitable for
FIG. 3. Apoptin fragments containing either the NES or the NLS
fail to undergo cell type-specific localization. (Top) Schematic dia-
grams of GFP-Apoptin deletion mutant derivatives. (Middle) Fluores-
cence microscopy of H1299 and PFFs expressing GFP-Apoptin deriv-
atives. (Bottom) Quantification of the nuclear/cytoplasmic GFP signal
ratio for the images presented in the middle panel.
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FIG. 4. Apoptin localization signals are modular and can cooperate in trans to confer cell type-specific localization. (A) H1299 (left panels) and
PFF (right panels) cells expressing GFP-Ap-pmNLS, dsRed-Ap-pmNES, or both were monitored by fluorescence microscopy. (Far right)
Quantification of the nuclear/cytoplasmic GFP signal ratio for the images presented in the panels on the left. (B) H1299 cells were transfected with
GFP-Apoptin mutants and 12 h later infected with Ad-Apwt. Apoptin multimerization was monitored by immunoprecipitation of Flag-tagged
Apoptin using an -Flag affinity resin, followed by analysis of the immunoprecipitate (IP) for GFP-Apoptin by immunoblotting with an -GFP
antibody. Expression of the GFP-Apoptin mutants and Flag-Apoptin were also monitored in whole-cell extracts (WCE). Samples were normalized
by equivalent cell number. (C) H1299 (left panels) and PFF (right panels) cells were cotransfected with GFP-Ap(1-88) and either dsRed-Apwt
(top), dsRed-Ap-pmNES (middle), or dsRed-Ap(82-121) (bottom) and monitored by fluorescence microscopy. (Far right) Quantification of the
nuclear/cytoplasmic GFP signal ratio for the images presented in panels on the left.
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immunofluorescence (data not shown), to test this prediction
we performed immunofluorescence for Cdc27 (also known as
APC3), a core APC/C subunit routinely used as a marker for
APC/C localization (17, 35). H1299 cells were transiently
transfected with a plasmid expressing dsRed-Apwt, incubated
for 12 h, fixed, and stained with an -Cdc27 antibody.
Figure 7A shows that dsRed-Apwt colocalized with Cdc27 in
the nucleus of transformed cells. However, we failed to detect
Cdc27 immunofluorescence in the presence of the Ap-
pmNLS2 mutant, which, unlike wild-type Apoptin (42), does
not associate with the APC/C and fails to induce apoptosis
(Fig. 6C) and G2/M arrest (data not shown). This result is
consistent with previous reports showing that several APC/C
subunits, including Cdc27, are detected only in mitotic and not
in interphase cells (16, 19).
It has recently been reported that Apoptin associates with
PML nuclear bodies (34). To verify this result, cells were trans-
fected with either dsRed-Apwt or, as a control, dsRed-Ap-
pmNLS2 and stained with an -PML antibody. Figure 7B
confirms that wild-type Apoptin colocalized with PML bodies
FIG. 5. The specific Apoptin NES is required for cell type-specific localization and overlaps with the multimerization domain. (A) Fluorescence
microscopy of H1299 and PFFs expressing GFP-Apoptin derivatives in which either the NLS was replaced by the SV40 NLS (top) or the NES was
replaced by the HIV-1 Rev NES (bottom). (Right) Quantification of the nuclear/cytoplasmic GFP signal ratio for the images presented in panels
on the left. (B) Apoptin multimerization was monitored as described for Fig. 4B.
FIG. 6. Functionality of both localization signals is critical for APC1 interaction and Apoptin-induced cell death. (A) Schematic diagrams of
Apoptin NLS mutations. (B) Fluorescence microscopy of H1299 cells expressing GFP-Ap-pmNLS2. (C) (Top) Apoptosis assays. H1299 cells were
transfected with GFP-Apwt, GFP-Ap-pmNLS2, or GFP-Ap-SV40NLS and, after 72 h, fixed, stained with DAPI and analyzed by fluorescence
microscopy for GFP expression associated with apoptotic morphology. The percent apoptosis in cells expressing GFP alone was taken as the
background and subtracted from all samples. All mutant samples are shown as the percent apoptosis of GFP-Apwt. (Inset) Expression of
GFP-Apwt, GFP-Ap-pmNLS2, and GFP-Ap-SV40NLS 24 h after transfection. (Bottom) APC1 association. H1299 cells expressing Flag-tagged
versions of Apoptin mutants were immunoprecipitated with an -Flag antibody, and the immunoprecipitate was analyzed for APC1 and Apoptin
by immunoblotting. Sample loading was normalized by equivalent cell number. (D) (Top) PFF or H1299 cells were infected with Ad-LacZ,
Ad-Apwt, or Ad-Ap-pmNES, and 72 h later the cell viability was quantified by flow cytometry. (Bottom) APC1 association. Samples were
normalized by equivalent cell number. (E) DnRan shuttling assay, performed as described for Fig. 1C.
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within the nucleus of transformed cells. Significantly, in cells
transfected with dsRed-Ap-pmNLS2, PML immunofluores-
cence was undetectable, a finding consistent with previous
studies showing that in H1299 cells PML nuclear body forma-
tion occurs only under conditions of apoptotic stimuli (11).
Thus, Apoptin induces the formation of PML nuclear bodies in
transformed cells in a manner that requires APC/C interaction.
The results described above indicate that Apoptin colocal-
izes with the APC/C (Fig. 7A) and that Apoptin is present in
PML bodies (Fig. 7B). These results strongly suggested that in
cells expressing Apoptin, APC/C would be present in PML
bodies. To provide direct evidence for this supposition, plas-
mids expressing either dsRed-Apwt or dsRed-Ap-pmNLS2
were cotransfected into H1299 cells with a plasmid constitu-
tively expressing PML fused to the C terminus of cyan fluo-
rescent protein (CFP-PML). At 12 h after transfection, cells
were fixed and stained with an -Cdc27 antibody. Figure 7C
shows that, as expected, dsRed-Apwt, Cdc27 and CFP-PML
colocalized in the nucleus of transformed cells. Thus, in the
presence of Apoptin, the APC/C becomes sequestered in PML
bodies.
DISCUSSION
We show here for the first time that Apoptin is a nucleocy-
toplasmic shuttling protein with a modular structure organized
into overlapping functional domains. Whereas previous studies
have implicated the existence of putative localization se-
quences, here we conclusively delineate functional NES and
NLS sequences and their respective activities in both primary
and transformed cells. A Crm1-dependent NES at the N ter-
minus overlaps with a domain required for Apoptin multimer-
ization, whereas the NLS at the C terminus overlaps with the
APC1 interaction domain (Fig. 8A). Overlapping functional
domains is a common theme among viruses, which have com-
pact genomes. In particular, the existence of domains that
overlap with NES and NLS sequences has been implicated in
the regulation of at least one other viral protein, HIV-1 Rev (4,
46). Together the NES, NLS, multimerization, and APC1 in-
teraction domains impart Apoptin with the differential local-
ization, biochemical behavior, and protein interactions that
provide the basis for selective killing of transformed cells. The
results in the present study allow us to propose a model for
how Apoptin selectively kills transformed cells (presented in
Fig. 8B and discussed below).
Role of nucleocytoplasmic shuttling. Unexpectedly, we found
that nucleocytoplasmic shuttling is required for both cell type-
specific localization and the induction of apoptosis. The equi-
librium dynamics of Apoptin nucleocytoplasmic shuttling pro-
vides a powerful mechanism for inducing rapid changes in
protein localization with minimal changes in cellular activities.
Such rapid changes in protein localization and apoptosis in-
duction may be important for the timing of the CAV life cycle
and viral egress.
FIG. 7. Apoptin colocalizes with APC/C within PML bodies in the
nuclei of transformed cells. (A and B) H1299 cells were transiently
transfected with a plasmid expressing either dsRed-Apwt or dsRed-
Ap-pmNLS2 and, after a 12-h incubation, were fixed and stained with
an -Cdc27 antibody (A) or an -PML antibody (B). (C) H1299 cells
were cotransfected with plasmids expressing either dsRed-Apwt or
dsRed-Ap-NLS2 and a plasmid expressing CFP-PML. At 12 h after
transfection, cells were fixed and stained with an -Cdc27 antibody.
FIG. 8. Multifunctional localization signals mediate the cell type-
specific localization of Apoptin. (A) Schematic diagram of Apoptin’s
localization signals and overlapping protein interaction domains. (B) A
model for the transformed cell-specific killing activity of Apoptin. In
transformed cells, Apoptin shuttling is shifted toward nuclear accumu-
lation. The localization of APC/C subunits is not clear; Apoptin may
either transport APC/C subunits from the cytoplasm to the nucleus or
associate with APC/C subunits already present in the nucleus. Apop-
tin-mediated recruitment of APC/C into PML nuclear bodies in trans-
formed cells leads to inactivation of APC/C function and subsequent
induction of G2/M arrest and apoptosis.
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The results presented here and in our previous study (42)
indicate that APC1 is a critical target of Apoptin. The APC/C
complex has essential nuclear functions such as chromosome
segregation and cyclin turnover (33). However, recent stud-
ies suggest that many of the APC/C subunits, and perhaps
specific APC/C subcomplexes, reside predominantly in the
cytoplasm and only transiently associate with nuclear com-
ponents during mitosis (16, 17, 44). Thus, the nucleocyto-
plasmic shuttling activity of Apoptin may function to transport
APC/C from the cytoplasm to the nucleus, where it is depos-
ited into PML nuclear bodies. Consistent with this proposal,
Apoptin mutants that are defective in shuttling show a greatly
reduced ability to interact with APC1 and fail to induce apop-
tosis (Fig. 6D and E).
Role of multimerization. The multimerization state of Apoptin
appears to vary in degree between cell types and affects its local-
ization and apoptotic activities. Although the physical basis of this
phenomenon remains to be explained, a higher state of multi-
merization in primary cells could explain the aggregation, insolu-
bility, and retention of Apoptin in the cytoplasm. Multimerization
is also required to establish a high-affinity interaction with APC1,
since Apoptin mutants that are decreased in multimerization dis-
play a reduced affinity for APC1. Although previous studies have
suggested that Apoptin multimerization occurs through direct
Apoptin-Apoptin interaction (28), it remains possible that Apop-
tin molecules associate indirectly through one or more cellular
bridging proteins.
Regulation of Apoptin localization and activity. In the
present study we have shown that Apoptin nuclear localization
is mediated by a dominant transformed cell-specific activity.
However, the nature of the cell type-specific modification that
controls Apoptin localization change remains unclear. Some
studies (34, 37) have reported that Apoptin regulated localiza-
tion is controlled by cell-specific phosphorylation on threo-
nine-108 at the C terminus (47). In contrast, we have found
that Apoptin derivatives in which the C-terminal region is
substituted by heterologous sequences localize normally (see
Fig. 5A), indicating that Apoptin sequences at the C terminus
are dispensable for regulated localization. Instead, our results
indicate that the N-terminal region of Apoptin, containing the
NES and multimerization domain, when coupled to a generic
NLS activity, mediates regulated localization (see Fig. 5A).
This result raises the possibility that the dominant transformed
cell-specific activity may negatively regulate the NES, which, in
turn, favors NLS function and nuclear localization. In addition,
our results are consistent with studies that have shown that the
NLS region is not sufficient to confer transformed cell-specific
nuclear localization (9, 47). In contrast to that study (47),
however, we (42) and others (36) found no evidence that the
cellular concentration of Apoptin has any effect on localiza-
tion.
Role of PML body induction and colocalization with APC/C.
We have shown that introduction of Apoptin into transformed
cells results in the formation of PML nuclear bodies and the
recruitment of Apoptin-APC/C complexes into these sub-
nuclear structures. The localization of APC/C subunits to PML
bodies is a direct result of recruitment by Apoptin and not an
indirect consequence of the G2/M arrest: in the absence of
Apoptin, PML bodies are not detectable (reference 11 and
data not shown), and PML itself is present at very low levels in
G2/M (53).
Several studies have shown that cells respond to various
types of stimuli by increasing both the size and the number of
PML nuclear bodies (11, 23, 43). In addition to established
roles in tumor suppression and senescence (reviewed in
reference 10), PML nuclear bodies play an integral role in
apoptotic processes and have been proposed to serve as a
“hub” for nuclear apoptotic reinforcement (5). Cells derived
from PML/ knockout mice are virtually resistant to apop-
tosis stimulated by intrinsic as well as extrinsic stimuli, indicat-
ing a strong connection between PML body formation and
induction or execution of programmed cell death. Interest-
ingly, PML nuclear bodies have been implicated in the execu-
tion of p53-independent (as well as p53-dependent) apoptotic
programs (48, 49, 54), an important aspect of Apoptin-induced
cell death. PML nuclear bodies are potential centers for the
control and regulation of proteins by posttranslational modi-
fication (e.g., sumoylation, acetylation, and ubiquitination) and
by degradation (2, 26, 27). For example, many cellular and viral
sumoylated proteins are targeted to PML nuclear bodies (39).
In many cases, however, the functional significance between
protein modification and PML localization remains unclear.
Interestingly, studies in yeast have shown that the mitotic func-
tions of the APC/C are modulated by sumoylation and ubiq-
uitination (12). Thus, the Apoptin-mediated recruitment of
APC/C components (or subcomplexes) into PML nuclear bod-
ies suggests a functional connection between Apoptin-APC/C
interaction, cyclosome inhibition and induction of apoptosis.
Abrogation of APC/C activity through targeting to PML nu-
clear bodies provides a method by which APC/C could be
sequestered and inhibited, and apoptotic programming of nu-
clear origin could ensue.
Inhibition of the APC/C may represent a major tumor sup-
pressor mechanism (reviewed in reference 14). For example,
the endogenous APC/C inhibitor RASSF1 is mutated in some
human cancers (1). In addition, dysfunction of APC/C and
mitotic checkpoint function has been suggested to contribute
to transformation and could lead to properties in cancer cells
such as unscheduled proliferation and aneuploidy. Several viral
proteins, including the adenovirus E4orf4, human T lympho-
trophic virus type 1 Tax, and an as-yet-unidentified protein
from cytomegalovirus, interact with the APC/C and deregulate
its activity (24, 29, 51). These independently evolved viral
mechanisms of targeting APC/C also suggest an underlying
role for the APC/C as a nodal point in cell cycle control and
tumor suppression.
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